Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHEST: Hydroxyethyl Starch vs Saline in ICU
NCT00935168Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- Dec 2009
- Primary completion
- Apr 2012
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetastarch in hypovolemia, sponsored by The George Institute for Global Health. Started Dec 2009; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT00935168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00935168.